Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Munir, Talha [1 ]
Mohseninejad, Leyla [2 ]
Xu, Sheng [3 ]
Jevdjevic, Milica [4 ]
Bouwmeester, Walter [4 ]
Yang, Keri [5 ]
机构：
[1] St James Univ Hosp, Dept Haematol, Leeds, W Yorkshire, England
[2] BeiGene Netherlands BV, Schiphol, Netherlands
[3] BeiGene Shanghai Co Ltd, Shanghai, Peoples R China
[4] PRECISIONheor, London, England
[5] BeiGene USA, San Mateo, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
    Shadman, Mazyar
    Tedeschi, Alessandra
    Mohseninejad, Leyla
    Yang, Keri
    Lamanna, Nicole
    Xu, Sheng
    Cohen, Aileen Cleary
    Challagulla, Swetha
    Xue, Mei
    Williams, Rhys
    O'Brien, Susan M.
    Brown, Jennifer R.
    Tam, Constantine S.
    BLOOD, 2023, 142
  • [32] Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Song, Jinlin
    Ma, Qiufei
    Gao, Wei
    Cong, Ze
    Xie, Jipan
    Zimmerman, Zachary
    Belton, Laura
    Franklin, Janet
    Palmer, Stephen
    ADVANCES IN THERAPY, 2019, 36 (04) : 950 - 961
  • [33] Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison
    Shadman, Mazyar
    Tedeschi, Alessandra
    Mohseninejad, Leyla
    Yang, Keri
    Lamanna, Nicole
    Xu, Sheng
    Cohen, Aileen
    Challagulla, Swetha
    Xue, Mei
    Williams, Rhys
    O'Brien, Susan M.
    Brown, Jennifer R.
    Tam, Constantine
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [34] Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Jinlin Song
    Qiufei Ma
    Wei Gao
    Ze Cong
    Jipan Xie
    Zachary Zimmerman
    Laura Belton
    Janet Franklin
    Stephen Palmer
    Advances in Therapy, 2019, 36 : 950 - 961
  • [35] A matching-adjusted indirect comparison of trabectedin and pazopanib for the treatment of advanced, metastatic, leiomyosarcomas
    Jones, R. L.
    Blay, J-Y.
    Lecesne, A.
    Martin-Broto, J.
    Pontes, M. J.
    Fernandez Santos, J. M.
    Garcia San Andres, B.
    Wang, G.
    Wang, S.
    Shin, C. R.
    Maki, R.
    Patel, S.
    Demetri, G. D. S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Early Ofatumumab Treatment For High-Risk, Treatment-Naive Patients With Chronic Lymphocytic Leukemia
    Jain, Nitin
    Keating, Michael J.
    Ferrajoli, Alessandra
    Konopleva, Marina
    Thomas, Deborah A.
    Pemmaraju, Naveen
    DiNardo, Courtney D.
    O'Brien, Susan
    Wierda, William G.
    BLOOD, 2013, 122 (21)
  • [37] LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA
    Autore, F.
    Strati, P.
    Innocenti, I.
    Corrente, F.
    Trentin, L.
    Cortelezzi, A.
    Visco, C.
    Coscia, M.
    Cuneo, A.
    Gozzetti, A.
    Mauro, F. R.
    Montillo, M.
    Gentile, M.
    Morabito, F.
    Molica, S.
    Falcucci, P.
    D'Arena, G.
    Murru, R.
    Vincelli, D.
    Galieni, P.
    Reda, G.
    Tisi, M. C.
    Vitale, C.
    Rigolin, G. M.
    Ferrajoli, A.
    Laurenti, L.
    HAEMATOLOGICA, 2017, 102 : 707 - 707
  • [38] Comparative effectiveness of secukinumab and etanercept in biologic-naive patients with psoriatic arthritis assessed by matching-adjusted indirect comparison
    Mease, Philip
    Choy, Ernest
    Nash, Peter
    Kalyvas, Chrysostomos
    Hunger, Matthias
    Pricop, Luminita
    Gandhi, Kunal K.
    Jugl, Steffen M.
    Thom, Howard
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (03) : 113 - +
  • [39] LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA
    Autore, F.
    Strati, P.
    Innocenti, I.
    Corrente, F.
    Trentin, L.
    Cortelezzi, A.
    Visco, C.
    Coscia, M.
    Cuneo, A.
    Gozzetti, A.
    Mauro, F. R.
    Montillo, M.
    Gentile, M.
    Morabito, F.
    Molica, S.
    Falcucci, P.
    D'Arena, G.
    Murru, R.
    Vincelli, D.
    Galieni, P.
    Reda, G.
    Tisi, M. C.
    Vitale, C.
    Rigolin, G. M.
    Ferrajoli, A.
    Laurenti, L.
    HAEMATOLOGICA, 2017, 102 : 116 - 117
  • [40] Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naive Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison
    Robak, Tadeusz
    Burger, Jan A.
    Tedeschi, Alessandra
    Barr, Paul M.
    Owen, Carolyn Jane
    Bairey, Osnat
    Hillmen, Peter
    Simpson, David
    Grosicki, Sebastian
    Devereux, Stephen
    McCarthy, Helen
    Coutre, Steven
    Hang Quach
    Gaidano, Gianluca
    Maslyak, Zvenyslava
    Stevens, Don A.
    Moreno, Carol
    Gill, Devinder
    Flinn, Ian W.
    Gribben, John
    Mokatrin, Ahmad
    Cheng, Mei
    Styles, Lori
    James, Danelle F.
    Kipps, Thomas J.
    Ghia, Paolo
    BLOOD, 2017, 130
12345